Concord Medical Services Stock Filter Stocks by Fundamentals
| CCM Stock | USD 0.58 0.05 7.94% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
Concord | Cash Flow from Operations |
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 806.0M | 781.1M | 556.7M | 494.1M | 568.2M | 539.8M | |
| Enterprise Value | 2.6B | 2.8B | 3.1B | 3.6B | 3.2B | 1.7B |
Concord Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.0498 | ||||
| Profit Margin | (0.76) % | ||||
| Operating Margin | (0.75) % | ||||
| Current Valuation | 7.06 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 17.99 % | ||||
| Shares Owned By Institutions | 0.10 % | ||||
| Number Of Shares Shorted | 14.54 K | ||||
| Price To Earning | (3.90) X | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 472.08 M | ||||
| Gross Profit | (152.41 M) | ||||
| EBITDA | (581.17 M) | ||||
| Net Income | (768.99 M) | ||||
| Cash And Equivalents | 157.39 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 3.24 B | ||||
| Debt To Equity | 1.25 % | ||||
| Current Ratio | 0.71 X | ||||
| Book Value Per Share | (42.96) X | ||||
| Cash Flow From Operations | (216.69 M) | ||||
| Short Ratio | 0.64 X | ||||
| Earnings Per Share | (1.48) X | ||||
| Target Price | 1.2 | ||||
| Number Of Employees | 918 | ||||
| Beta | -0.17 | ||||
| Market Capitalization | 27.49 M | ||||
| Total Asset | 6 B | ||||
| Retained Earnings | (3.77 B) | ||||
| Working Capital | (361.44 M) | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 1.51 B | ||||
| Net Asset | 6 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Concord Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Concord Stock
| 0.63 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Concord Stock
| 0.87 | ELMD | Electromed | PairCorr |
| 0.83 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
| 0.8 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.79 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
| 0.73 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.
The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 14.017 | Quarterly Revenue Growth 0.972 | Return On Assets (0.05) | Return On Equity (0.31) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.